Controlled clinical trials (CCTs) are needed to determine if a difference is present between two or more interventions (e.g, medication versus placebo). Most biomedical journals require an author to conform to a standarized format to report a CCT. The preparation of the manuscript according to this manner increases the readability and comprehension plus enables the readers to quickly locate pertinent information. Although guidelines have been developed to prepare and report CCTs, limitations are present and errors do occur; no study design and author'S description is perfect. Thus, a CCT should be critiqued using literature analysis skills to identify study strengths and limitations that should be considered in interpreting the overall meaning of the trial. Furthermore, results of more than one CCT should be analyzed before changing practice habits since no one study answers all of the questions and addresses all the issues.
Friedman Lm,Furberg Cd,Demets DlFundamentals of clinical trials. 3rd ed.St. Louis (MO): Mosby Year Book; 1996:
2.
Riegelman Rk,Hirsch RpStudying a study and testing a test. how to read the health science literature.. 3rd ed.Boston (MA): Little, Brown and Company; 1996:
3.
Guyatt Gh,Sackett Dl,Cook Dj.User's guides to the medical literature. II. how to use an article about therapy or prevention. A. are the results of the study valid?.JAMA. 1993;270:2598-2601
4.
Dans Al,Dans Lf,Guyatt Gh.User's guides to the medical literature. XIV. how to decide on the applicability of clinical trial results to your patient.JAMA. 1998;279:545-549
5.
Greenhalgh T.How to read a paper: getting your bearing (deciding what the paper is about).BMJ. 1997;315:243-246
6.
Gehlbach ShInterpreting the medical literature. 3rd ed.New York (NY): McGraw-Hill, Inc; 1993:
7.
Wright Sg,Lecroy Rl,Kendrach Mg.A Review of the three types of biomedical literature and using the systematic approach to answer a drug information request.J Pharm Pract. 1998;11:148
8.
Uniform requirements for manuscripts submitted to biomedical journals.JAMA. 1997;277:927-934
9.
Checklist of information for inclusion in reports of clinical trials.Ann Intern Med. 1996;124:741-743
10.
Angell M,Kassirer Jp.Clinical research—what should the public believe [editorial]?.N Engl J Med. 1994;331:189-190
11.
Rapp Rp.Temafloxacin voluntary withdrawal: concerns about multicenter testing and postmarketing surveillance [editorial].Ann Pharmacother. 1992;26:996
12.
Adverse effects prompt withdrawal of temafloxacin.Clin Pharm. 1992;11:747
13.
Withdrawal of temafloxacin from the American market.Rev Prescr. 1993;13 (125): 22
14.
Naylor Cd.Meta-analysis and the metaepidemiology of clinical research [editorial].BMJ. 1997;315:617-619
15.
Smith R,Roberts I.An amnesty for unpublished trials [editorial].BMJ. 1997;315:622
16.
Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials.JAMA. 1998;279:21-286
Cuddy Pg,Elenbaas Rm,Elenbaas Jk.Evaluating the medical literature. part I: abstract, introduction, methods.Ann Emerg Med. 1983;12:549-555
19.
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.JAMA. 1982;247:1707-1714
20.
Echt Ds,Liebson Pr,Mitchell Lb.Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.N Engl J Med. 1991;324:781-788
21.
Pablos-Mendex A,Barr Rg,Shea S.Run-in periods in randomized trials. implications for the application of results in clinical practice.JAMA. 1998;279:222-225
22.
Senn S.Are placebo run in justified?.BMJ. 1997;314:1191-1193
23.
Ramsay Le.Commentary: placebo run ins have some value.BMJ. 1997;314:1193-1194
24.
Basskin L.How to evaluate the validity and usefulness of published randomized clinical trials.Formulary. 1997;32:279 280 283-286
25.
Greenhalgh T.How to read a paper: assessing the methodological quality of published papers.BMJ. 1997;315:305-308
26.
Greenhalgh T.How to read a paper: papers that report drug trials.BMJ. 1997;315:480-483
27.
Fleming Tr,Demets Dl.Surrogate end points in clinical trials: are we being misled?.Ann Intern Med. 1996;125:605-613
28.
Fleming Tr.Surrogate endpoints in clinical trials.Drug Inf J. 1996;30:545-551
29.
Pitt B,Segal R,Martinez Fa.Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).Lancet. 1997;349:747-752
30.
Anderson G,Kendrach Mg,Trice S.Understanding statistical and clinical significance: hypothesis testing.J Pharm Pract. 1998;11:181
31.
Ware Jh,Antman Em.Equivalence trials [editorial].N Engl J Med. 1997;337:1159-1161
32.
Elenbaas Jk,Cuddy Pg,Elenbass Rm.Evaluating the medical literature. part III: results and discussion.Ann Emerg Med. 1983;12:679-686
33.
Elenbaas Rm,Elenbaas Jk,Cuddy Pg.Evaluating the medical literature. part II: statistical analysis.Ann Emerg Med. 1983;12:610-620
34.
Gaddis Gm,Gaddis Ml.Introduction to biostatistics: part 4, statistical inference techniques in hypothesis testing.Ann Emerg Med. 1990;19:820-825
35.
Gaddis Gm,Gaddis Ml.Introduction to biostatistics: part 5, statistical inference techniques for hypothesis testing with nonparametric data.Ann Emerg Med. 1990;19:1054-1059
36.
Norman Gr,Streiner DlBiostatistics: the bare essentials. 1st ed.St. Louis (MO): Mosby Year Book, Inc; 1994:
Asmar Bi,Dajani As,Del-Beccaro Ma.Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children.Pediatrics. 1994;94:847-852
47.
Talan Da.Infectious disease issues in the emergency department.Clin Infect Dis. 1996;23:1-14
48.
Hamer Dh.IDCP guidelines: epiglottitis and otitis.Infect Dis Clin Pract. 1997;6:502-505
49.
McConnell Jd,Bruskewitz R,Walsh P.The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia.N Engl J Med. 1998;338:557-563
50.
Wasson Jh.Finasteride to prevent morbidity from benign prostatic hyperplasia [editorial].N Engl J Med. 1998;338:612-613
51.
Smith Dw,Kearney Pa.Notice of redundant publication: transesophageal echocardiography in the diagnosis of traumatic rupture of the aorta [authors reply to letters-to-the-editor].N Engl J Med. 1995;333:458
52.
Lynch Jp,Rothstein Rd.Not a “bee-zoar,” but a wasp.N Engl J Med. 1997;337:575-576
